MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
238.68%
Quick Ratio
131.56%
Cash Ratio
52.52%
Debt to Asset Ratio
46.08%
Unit: Thousand (K) dollars
Assets Breakdown
Intangible assets, net
Accounts receivable, net
Deferred tax assets
Others
Liabilities Breakdown
Additional paid-in capital
Long-term debt, net
Current portion of long-term deb...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
874,005
2,222,435
1,311,679
1,250,108
Short-term investments
0
0
248,930
227,731
Accounts receivable, net
1,061,047
903,914
908,214
790,266
Inventory
1,782,524
1,273,221
1,298,883
1,382,173
Other current assets
254,047
205,500
185,784
204,265
Total current assets
3,971,623
4,605,070
3,953,490
3,854,543
Long-term investments
0
0
492,242
512,937
Property, plant and equipment, net
989,994
958,071
952,508
1,038,187
Intangible assets, net
4,879,367
204,662
213,837
233,112
Goodwill
655,745
196,199
196,199
196,199
Deferred tax assets
888,575
1,500,598
1,508,697
1,509,109
Restricted cash equivalents
-
850,000
-
-
Other assets
338,138
276,416
277,049
270,781
Total assets
11,723,442
8,591,016
7,594,022
7,614,868
Accounts payable and accrued liabilities
1,005,793
793,152
759,031
798,438
Current portion of long-term debt, net
658,203
-
-
-
Total current liabilities
1,663,996
793,152
759,031
798,438
Long-term convertible debt, net
-
-
597,176
596,663
Long-term debt, net
3,527,939
1,430,282
-
-
Other long-term liabilities
209,815
155,475
150,816
163,056
Total liabilities
5,401,750
2,378,909
1,507,023
1,558,157
Common stock, 0.001 par value 500,000,000 shares authorized 193,535,556 and 192,300,101 shares issued and outstanding, respectively
194
193
192
192
Additional paid-in capital
6,037,019
5,966,868
5,956,582
5,900,968
Company common stock held by the nonqualified deferred compensation plan
11,233
10,450
10,508
11,291
Accumulated other comprehensive loss
-8,783
-4,237
-13,473
-33,937
Retained earnings
304,495
259,733
154,206
200,779
Total stockholders equity
6,321,692
6,212,107
6,086,999
6,056,711
Total liabilities and stockholders equity
11,723,442
8,591,016
7,594,022
7,614,868
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Inventory
$1,782,524K
(33.01%↑ Y/Y)
Accounts receivable, net
$1,061,047K
(23.98%↑ Y/Y)
Cash and cash
equivalents
$874,005K
(-28.00%↓ Y/Y)
Other current assets
$254,047K
(43.38%↑ Y/Y)
Intangible assets, net
$4,879,367K
(1936.29%↑ Y/Y)
Total current assets
$3,971,623K
(4.37%↑ Y/Y)
Property, plant and
equipment, net
$989,994K
(-3.92%↓ Y/Y)
Deferred tax assets
$888,575K
(-37.73%↓ Y/Y)
Goodwill
$655,745K
(234.22%↑ Y/Y)
Other assets
$338,138K
(35.69%↑ Y/Y)
Total assets
$11,723,442K
(57.23%↑ Y/Y)
Total liabilities and
stockholders equity
$11,723,442K
(57.23%↑ Y/Y)
Total stockholders
equity
$6,321,692K
(4.89%↑ Y/Y)
Total liabilities
$5,401,750K
(277.95%↑ Y/Y)
Company common stock
held by the...
$11,233K
(-3.78%↓ Y/Y)
Accumulated other
comprehensive loss
-$8,783K
(80.29%↑ Y/Y)
Additional paid-in capital
$6,037,019K
(3.17%↑ Y/Y)
Retained earnings
$304,495K
(31.52%↑ Y/Y)
Long-term debt, net
$3,527,939K
Total current
liabilities
$1,663,996K
(143.19%↑ Y/Y)
Other long-term
liabilities
$209,815K
(40.99%↑ Y/Y)
Common stock, 0.001 par
value 500,000,000...
$194K
(1.04%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,005,793K
(46.99%↑ Y/Y)
Current portion of
long-term debt, net
$658,203K
Buy us a coffee
biomarin-logo-svg
BIOMARIN PHARMACEUTICAL INC (BMRN)
biomarin-logo-svg
BIOMARIN PHARMACEUTICAL INC (BMRN)